{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:36:52Z","timestamp":1793853412567,"version":"4.6.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00134-023-06980-6","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T22:34:00Z","timestamp":1676673240000},"page":"273-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["How to manage coagulopathies in critically ill patients"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-6800","authenticated-orcid":false,"given":"Julie","family":"Helms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Gando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"6980_CR1","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/aas.12537","volume":"59","author":"E Hjorleifsson","year":"2015","unstructured":"Hjorleifsson E, Sigurdsson MI, Gudmundsdottir BR, Sigurdsson GH, Onundarson PT (2015) Prediction of survival in patients suspected of disseminated intravascular coagulation. Acta Anaesthesiol Scand 59:870\u2013880. https:\/\/doi.org\/10.1111\/aas.12537","journal-title":"Acta Anaesthesiol Scand"},{"key":"6980_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06834-7","author":"DJB Kleinveld","year":"2022","unstructured":"Kleinveld DJB, Hamada SR, Sandroni C (2022) Trauma-induced coagulopathy. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-022-06834-7","journal-title":"Intensive Care Med"},{"key":"6980_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/TA.0000000000002205","volume":"86","author":"RA Callcut","year":"2019","unstructured":"Callcut RA, Kornblith LZ, Conroy AS, Robles AJ, Meizoso JP, Namias N, Meyer DE, Haymaker A, Truitt MS, Agrawal V, Haan JM, Lightwine KL, Porter JM, San Roman JL, Biffl WL, Hayashi MS, Sise MJ, Badiee J, Recinos G, Inaba K, Schroeppel TJ, Callaghan E, Dunn JA, Godin S, McIntyre RC Jr, Peltz ED, O\u2019Neill PJ, Diven CF, Scifres AM, Switzer EE, West MA, Storrs S, Cullinane DC, Cordova JF, Moore EE, Moore HB, Privette AR, Eriksson EA, Cohen MJ, Western Trauma Association Multicenter Study G (2019) The why and how our trauma patients die: a prospective Multicenter Western Trauma Association study. J Trauma Acute Care Surg 86:864\u2013870. https:\/\/doi.org\/10.1097\/TA.0000000000002205","journal-title":"J Trauma Acute Care Surg"},{"key":"6980_CR4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1182\/hematology.2020000139","volume":"2020","author":"C McLintock","year":"2020","unstructured":"McLintock C (2020) Prevention and treatment of postpartum hemorrhage: focus on hematological aspects of management. Hematol Am Soc Hematol Educ Progr 2020:542\u2013546. https:\/\/doi.org\/10.1182\/hematology.2020000139","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"6980_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/jth.12078","volume":"11","author":"I Raza","year":"2013","unstructured":"Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De\u2019Ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K (2013) The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 11:307\u2013314. https:\/\/doi.org\/10.1111\/jth.12078","journal-title":"J Thromb Haemost"},{"key":"6980_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/TA.0000000000000792","volume":"79","author":"HB Moore","year":"2015","unstructured":"Moore HB, Moore EE, Morton AP, Gonzalez E, Fragoso M, Chapman MP, Dzieciatkowska M, Hansen KC, Banerjee A, Sauaia A, Silliman CC (2015) Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation. J Trauma Acute Care Surg 79:897\u2013903. https:\/\/doi.org\/10.1097\/TA.0000000000000792","journal-title":"J Trauma Acute Care Surg"},{"key":"6980_CR7","doi-asserted-by":"publisher","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","volume":"2","author":"S Gando","year":"2016","unstructured":"Gando S, Levi M, Toh CH (2016) Disseminated intravascular coagulation. Nat Rev Dis Primers 2:16037. https:\/\/doi.org\/10.1038\/nrdp.2016.37","journal-title":"Nat Rev Dis Primers"},{"key":"6980_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104\u2013107. https:\/\/doi.org\/10.1038\/nature08780","journal-title":"Nature"},{"key":"6980_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/09537104.2020.1718633","volume":"32","author":"P Vulliamy","year":"2021","unstructured":"Vulliamy P, Kornblith LZ, Kutcher ME, Cohen MJ, Brohi K, Neal MD (2021) Alterations in platelet behavior after major trauma: adaptive or maladaptive? Platelets 32:295\u2013304. https:\/\/doi.org\/10.1080\/09537104.2020.1718633","journal-title":"Platelets"},{"key":"6980_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/TA.0b013e318256deab","volume":"73","author":"ME Kutcher","year":"2012","unstructured":"Kutcher ME, Redick BJ, McCreery RC, Crane IM, Greenberg MD, Cachola LM, Nelson MF, Cohen MJ (2012) Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg 73:13\u201319. https:\/\/doi.org\/10.1097\/TA.0b013e318256deab","journal-title":"J Trauma Acute Care Surg"},{"key":"6980_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/TA.0000000000002707","volume":"89","author":"NE Starr","year":"2020","unstructured":"Starr NE, Matthay ZA, Fields AT, Nunez-Garcia B, Callcut RA, Cohen MJ, Kornblith LZ (2020) Identification of injury and shock driven effects on ex vivo platelet aggregometry: a cautionary tale of phenotyping. J Trauma Acute Care Surg 89:20\u201328. https:\/\/doi.org\/10.1097\/TA.0000000000002707","journal-title":"J Trauma Acute Care Surg"},{"key":"6980_CR12","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1182\/blood-2017-11-784108","volume":"131","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang F, Dong JF (2018) Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury. Blood 131:2001\u20132006. https:\/\/doi.org\/10.1182\/blood-2017-11-784108","journal-title":"Blood"},{"issue":"Suppl 1","key":"6980_CR13","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/S0049-3848(17)30069-5","volume":"151","author":"O Erez","year":"2017","unstructured":"Erez O (2017) Disseminated intravascular coagulation in pregnancy: clinical phenotypes and diagnostic scores. Thromb Res 151(Suppl 1):S56\u2013S60. https:\/\/doi.org\/10.1016\/S0049-3848(17)30069-5","journal-title":"Thromb Res"},{"key":"6980_CR14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/00005373-198208000-00004","volume":"22","author":"JL Kashuk","year":"1982","unstructured":"Kashuk JL, Moore EE, Millikan JS, Moore JB (1982) Major abdominal vascular trauma\u2013a unified approach. J Trauma 22:672\u2013679. https:\/\/doi.org\/10.1097\/00005373-198208000-00004","journal-title":"J Trauma"},{"key":"6980_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/TA.0000000000002614","volume":"88","author":"HB Moore","year":"2020","unstructured":"Moore HB, Tessmer MT, Moore EE, Sperry JL, Cohen MJ, Chapman MP, Pusateri AE, Guyette FX, Brown JB, Neal MD, Zuckerbraun B, Sauaia A (2020) Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock. J Trauma Acute Care Surg 88:588\u2013596. https:\/\/doi.org\/10.1097\/TA.0000000000002614","journal-title":"J Trauma Acute Care Surg"},{"key":"6980_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/TA.0000000000002570","volume":"88","author":"RM Ditzel Jr","year":"2020","unstructured":"Ditzel RM Jr, Anderson JL, Eisenhart WJ, Rankin CJ, DeFeo DR, Oak S, Siegler J (2020) A review of transfusion- and trauma-induced hypocalcemia: Is it time to change the lethal triad to the lethal diamond? J Trauma Acute Care Surg 88:434\u2013439. https:\/\/doi.org\/10.1097\/TA.0000000000002570","journal-title":"J Trauma Acute Care Surg"},{"key":"6980_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jss.2012.05.054","volume":"179","author":"AP Morton","year":"2013","unstructured":"Morton AP, Moore EE, Wohlauer MV, Lo K, Silliman CC, Burlew CC, Banerjee A (2013) Revisiting early postinjury mortality: are they bleeding because they are dying or dying because they are bleeding? J Surg Res 179:5\u20139. https:\/\/doi.org\/10.1016\/j.jss.2012.05.054","journal-title":"J Surg Res"},{"key":"6980_CR18","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1213\/ANE.0000000000004479","volume":"130","author":"AY Mitrophanov","year":"2020","unstructured":"Mitrophanov AY, Szlam F, Sniecinski RM, Levy JH, Reifman J (2020) Controlled multifactorial coagulopathy: effects of dilution, hypothermia, and acidosis on thrombin generation in vitro. Anesth Analg 130:1063\u20131076. https:\/\/doi.org\/10.1213\/ANE.0000000000004479","journal-title":"Anesth Analg"},{"key":"6980_CR19","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/TA.0000000000000341","volume":"77","author":"HB Moore","year":"2014","unstructured":"Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, Silliman CC, Banerjee A, Sauaia A (2014) Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg 77:811\u2013817. https:\/\/doi.org\/10.1097\/TA.0000000000000341","journal-title":"J Trauma Acute Care Surg"},{"key":"6980_CR20","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/TA.0000000000001410","volume":"82","author":"J Zipperle","year":"2017","unstructured":"Zipperle J, Altenburger K, Ponschab M, Schlimp CJ, Spittler A, Bahrami S, Redl H, Schochl H (2017) Potential role of platelet-leukocyte aggregation in trauma-induced coagulopathy: ex vivo findings. J Trauma Acute Care Surg 82:921\u2013926. https:\/\/doi.org\/10.1097\/TA.0000000000001410","journal-title":"J Trauma Acute Care Surg"},{"key":"6980_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/TA.0000000000001685","volume":"83","author":"CD Barrett","year":"2017","unstructured":"Barrett CD, Moore HB, Banerjee A, Silliman CC, Moore EE, Yaffe MB (2017) Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin. J Trauma Acute Care Surg 83:1053\u20131061. https:\/\/doi.org\/10.1097\/TA.0000000000001685","journal-title":"J Trauma Acute Care Surg"},{"key":"6980_CR22","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1111\/jth.15074","volume":"18","author":"TF Wang","year":"2020","unstructured":"Wang TF, Makar RS, Antic D, Levy JH, Douketis JD, Connors JM, Carrier M, Zwicker JI (2020) Management of hemostatic complications in acute leukemia: guidance from the SSC of the ISTH. J Thromb Haemost 18:3174\u20133183. https:\/\/doi.org\/10.1111\/jth.15074","journal-title":"J Thromb Haemost"},{"key":"6980_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1055\/a-1393-8302","volume":"41","author":"H Ten Cate","year":"2021","unstructured":"Ten Cate H, Leader A (2021) Management of disseminated intravascular coagulation in acute leukemias. Hamostaseologie 41:120\u2013126. https:\/\/doi.org\/10.1055\/a-1393-8302","journal-title":"Hamostaseologie"},{"issue":"Suppl 1","key":"6980_CR24","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S0049-3848(20)30399-6","volume":"191","author":"MA Sanz","year":"2020","unstructured":"Sanz MA, Montesinos P (2020) Advances in the management of coagulopathy in acute promyelocytic leukemia. Thromb Res 191(Suppl 1):S63\u2013S67. https:\/\/doi.org\/10.1016\/S0049-3848(20)30399-6","journal-title":"Thromb Res"},{"key":"6980_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.thromres.2014.11.026","volume":"135","author":"M Mitrovic","year":"2015","unstructured":"Mitrovic M, Suvajdzic N, Elezovic I, Bogdanovic A, Djordjevic V, Miljic P, Djunic I, Gvozdenov M, Colovic N, Virijevic M, Lekovic D, Vidovic A, Tomin D (2015) Thrombotic events in acute promyelocytic leukemia. Thromb Res 135:588\u2013593. https:\/\/doi.org\/10.1016\/j.thromres.2014.11.026","journal-title":"Thromb Res"},{"key":"6980_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.beha.2008.12.007","volume":"22","author":"E Stein","year":"2009","unstructured":"Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS (2009) The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol 22:153\u2013163. https:\/\/doi.org\/10.1016\/j.beha.2008.12.007","journal-title":"Best Pract Res Clin Haematol"},{"key":"6980_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1365-2141.1989.tb06311.x","volume":"71","author":"B Bennett","year":"1989","unstructured":"Bennett B, Booth NA, Croll A, Dawson AA (1989) The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination. Br J Haematol 71:511\u2013517. https:\/\/doi.org\/10.1111\/j.1365-2141.1989.tb06311.x","journal-title":"Br J Haematol"},{"key":"6980_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ajh.20337","volume":"79","author":"M Graf","year":"2005","unstructured":"Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H (2005) High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis. Am J Hematol 79:26\u201335. https:\/\/doi.org\/10.1002\/ajh.20337","journal-title":"Am J Hematol"},{"key":"6980_CR29","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/10245332.2018.1470069","volume":"23","author":"P Wang","year":"2018","unstructured":"Wang P, Zhang Y, Yang H, Hou W, Jin B, Hou J, Li H, Zhao H, Zhou J (2018) Characteristics of fibrinolytic disorders in acute promyelocytic leukemia. Hematology 23:756\u2013764. https:\/\/doi.org\/10.1080\/10245332.2018.1470069","journal-title":"Hematology"},{"key":"6980_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1055\/s-0039-1693478","volume":"45","author":"HC Kwaan","year":"2019","unstructured":"Kwaan HC, Weiss I, Tallman MS (2019) The role of abnormal hemostasis and fibrinolysis in morbidity and mortality of acute promyelocytic leukemia. Semin Thromb Hemost 45:612\u2013621. https:\/\/doi.org\/10.1055\/s-0039-1693478","journal-title":"Semin Thromb Hemost"},{"key":"6980_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1055\/s-0041-1725099","volume":"47","author":"ST Bonlokke","year":"2021","unstructured":"Bonlokke ST, Ommen HB, Hvas AM (2021) Altered fibrinolysis in hematological malignances. Semin Thromb Hemost 47:569\u2013580. https:\/\/doi.org\/10.1055\/s-0041-1725099","journal-title":"Semin Thromb Hemost"},{"key":"6980_CR32","first-page":"150","volume":"11","author":"J Boisrame-Helms","year":"2013","unstructured":"Boisrame-Helms J, Kremer H, Schini-Kerth V, Meziani F (2013) Endothelial dysfunction in sepsis. Curr Vasc Pharmacol 11:150\u2013160","journal-title":"Curr Vasc Pharmacol"},{"key":"6980_CR33","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1097\/CCM.0b013e318258ff30","volume":"40","author":"F Fourrier","year":"2012","unstructured":"Fourrier F (2012) Severe sepsis, coagulation, and fibrinolysis: dead end or one way? Crit Care Med 40:2704\u20132708. https:\/\/doi.org\/10.1097\/CCM.0b013e318258ff30","journal-title":"Crit Care Med"},{"key":"6980_CR34","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2005-04-1710","volume":"106","author":"DA Lane","year":"2005","unstructured":"Lane DA, Philippou H, Huntington JA (2005) Directing thrombin. Blood 106:2605\u20132612. https:\/\/doi.org\/10.1182\/blood-2005-04-1710","journal-title":"Blood"},{"key":"6980_CR35","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-01-0053","author":"T van der Poll","year":"2014","unstructured":"van der Poll T, Herwald H (2014) The coagulation system and its function in early immune defense. Thromb Haemost. https:\/\/doi.org\/10.1160\/TH14-01-0053","journal-title":"Thromb Haemost"},{"key":"6980_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13613-017-0339-5","volume":"7","author":"X Delabranche","year":"2017","unstructured":"Delabranche X, Helms J, Meziani F (2017) Immunohaemostasis: a new view on haemostasis during sepsis. Ann Intensive Care 7:117. https:\/\/doi.org\/10.1186\/s13613-017-0339-5","journal-title":"Ann Intensive Care"},{"key":"6980_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/s-0037-1617143","volume":"30","author":"M Levi","year":"2010","unstructured":"Levi M (2010) The coagulant response in sepsis and inflammation. Hamostaseologie 30:10\u201316","journal-title":"Hamostaseologie"},{"issue":"Suppl 1","key":"6980_CR38","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.thromres.2014.03.016","volume":"133","author":"S Pfeiler","year":"2014","unstructured":"Pfeiler S, Massberg S, Engelmann B (2014) Biological basis and pathological relevance of microvascular thrombosis. Thromb Res 133(Suppl 1):S35-37. https:\/\/doi.org\/10.1016\/j.thromres.2014.03.016","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"6980_CR39","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1111\/jth.12977","volume":"13","author":"TJ Gould","year":"2015","unstructured":"Gould TJ, Lysov Z, Liaw PC (2015) Extracellular DNA and histones: double-edged swords in immunothrombosis. J Thromb Haemost 13(Suppl 1):S82-91. https:\/\/doi.org\/10.1111\/jth.12977","journal-title":"J Thromb Haemost"},{"key":"6980_CR40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fimmu.2016.00302","volume":"7","author":"H Yang","year":"2016","unstructured":"Yang H, Biermann MH, Brauner JM, Liu Y, Zhao Y, Herrmann M (2016) New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation. Front Immunol 7:302. https:\/\/doi.org\/10.3389\/fimmu.2016.00302","journal-title":"Front Immunol"},{"key":"6980_CR41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/SHK.0000000000000980","volume":"49","author":"L Stiel","year":"2018","unstructured":"Stiel L, Meziani F, Helms J (2018) Neutrophil activation during septic shock. Shock 49:371\u2013384. https:\/\/doi.org\/10.1097\/SHK.0000000000000980","journal-title":"Shock"},{"key":"6980_CR42","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532\u20131535. https:\/\/doi.org\/10.1126\/science.1092385","journal-title":"Science"},{"key":"6980_CR43","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1182\/blood-2013-04-457671","volume":"122","author":"BG Yipp","year":"2013","unstructured":"Yipp BG, Kubes P (2013) NETosis: how vital is it? Blood 122:2784\u20132794. https:\/\/doi.org\/10.1182\/blood-2013-04-457671","journal-title":"Blood"},{"key":"6980_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/cc9231","volume":"14","author":"F Meziani","year":"2010","unstructured":"Meziani F, Delabranche X, Asfar P, Toti F (2010) Bench-to-bedside review: circulating microparticles\u2013a new player in sepsis? Crit Care 14:236. https:\/\/doi.org\/10.1186\/cc9231","journal-title":"Crit Care"},{"key":"6980_CR45","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1097\/CCM.0b013e3181a00629","volume":"37","author":"S Mortaza","year":"2009","unstructured":"Mortaza S, Martinez MC, Baron-Menguy C, Burban M, de la Bourdonnaye M, Fizanne L, Pierrot M, Cales P, Henrion D, Andriantsitohaina R, Mercat A, Asfar P, Meziani F (2009) Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats. Crit Care Med 37:2045\u20132050. https:\/\/doi.org\/10.1097\/CCM.0b013e3181a00629","journal-title":"Crit Care Med"},{"key":"6980_CR46","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3324\/haematol.2012.066167","volume":"97","author":"R Lacroix","year":"2012","unstructured":"Lacroix R, Plawinski L, Robert S, Doeuvre L, Sabatier F, Martinez de Lizarrondo S, Mezzapesa A, Anfosso F, Leroyer AS, Poullin P, Jourde N, Njock MS, Boulanger CM, Angles-Cano E, Dignat-George F (2012) Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica 97:1864\u20131872. https:\/\/doi.org\/10.3324\/haematol.2012.066167","journal-title":"Haematologica"},{"key":"6980_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann B, Massberg S (2013) Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 13:34\u201345. https:\/\/doi.org\/10.1038\/nri3345","journal-title":"Nat Rev Immunol"},{"key":"6980_CR48","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nm.2184","volume":"16","author":"S Massberg","year":"2010","unstructured":"Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, Konrad I, Kennerknecht E, Reges K, Holdenrieder S, Braun S, Reinhardt C, Spannagl M, Preissner KT, Engelmann B (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16:887\u2013896. https:\/\/doi.org\/10.1038\/nm.2184","journal-title":"Nat Med"},{"key":"6980_CR49","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1055\/s-0039-1687890","volume":"45","author":"M Levi","year":"2019","unstructured":"Levi M (2019) Disseminated intravascular coagulation in cancer: an update. Semin Thromb Hemost 45:342\u2013347. https:\/\/doi.org\/10.1055\/s-0039-1687890","journal-title":"Semin Thromb Hemost"},{"key":"6980_CR50","doi-asserted-by":"publisher","first-page":"6S8","DOI":"10.1016\/S2542-4513(20)30514-9","volume":"45","author":"O Leiva","year":"2020","unstructured":"Leiva O, Newcomb R, Connors JM, Al-Samkari H (2020) Cancer and thrombosis: new insights to an old problem. J Med Vasc 45:6S8-6S16. https:\/\/doi.org\/10.1016\/S2542-4513(20)30514-9","journal-title":"J Med Vasc"},{"issue":"Suppl 1","key":"6980_CR51","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/S0049-3848(20)30391-1","volume":"191","author":"M Levi","year":"2020","unstructured":"Levi M, Sivapalaratnam S (2020) An overview of thrombotic complications of old and new anticancer drugs. Thromb Res 191(Suppl 1):S17\u2013S21. https:\/\/doi.org\/10.1016\/S0049-3848(20)30391-1","journal-title":"Thromb Res"},{"key":"6980_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1055\/s-2008-1079253","volume":"34","author":"FR Rickles","year":"2008","unstructured":"Rickles FR, Brenner B (2008) Tissue factor and cancer. Semin Thromb Hemost 34:143\u2013145. https:\/\/doi.org\/10.1055\/s-2008-1079253","journal-title":"Semin Thromb Hemost"},{"key":"6980_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jth.12075","volume":"11","author":"A Falanga","year":"2013","unstructured":"Falanga A, Marchetti M, Vignoli A (2013) Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 11:223\u2013233. https:\/\/doi.org\/10.1111\/jth.12075","journal-title":"J Thromb Haemost"},{"key":"6980_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-0-387-79962-9_4","volume":"148","author":"HC Kwaan","year":"2009","unstructured":"Kwaan HC, McMahon B (2009) The role of plasminogen-plasmin system in cancer. Cancer Treat Res 148:43\u201366. https:\/\/doi.org\/10.1007\/978-0-387-79962-9_4","journal-title":"Cancer Treat Res"},{"key":"6980_CR55","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1055\/s-0037-1616139","volume":"86","author":"S Sallah","year":"2001","unstructured":"Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G (2001) Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost 86:828\u2013833","journal-title":"Thromb Haemost"},{"key":"6980_CR56","doi-asserted-by":"publisher","first-page":"107602962110533","DOI":"10.1177\/10760296211053313","volume":"27","author":"J Weng","year":"2021","unstructured":"Weng J, Chen M, Fang D, Liu D, Guo R, Yang S (2021) Therapeutic Plasma exchange protects patients with sepsis-associated disseminated intravascular coagulation by improving endothelial function. Clin Appl Thromb Hemost 27:10760296211053312. https:\/\/doi.org\/10.1177\/10760296211053313","journal-title":"Clin Appl Thromb Hemost"},{"key":"6980_CR57","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1097\/PCC.0000000000002578","volume":"22","author":"AA El-Nawawy","year":"2021","unstructured":"El-Nawawy AA, Elshinawy MI, Khater DM, Moustafa AA, Hassanein NM, Wali YA, Nazir HF (2021) Outcome of early hemostatic intervention in children with sepsis and nonovert disseminated intravascular coagulation admitted to PICU: a randomized controlled trial. Pediatr Crit Care Med 22:e168\u2013e177. https:\/\/doi.org\/10.1097\/PCC.0000000000002578","journal-title":"Pediatr Crit Care Med"},{"key":"6980_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13054-020-2799-5","volume":"24","author":"K Stahl","year":"2020","unstructured":"Stahl K, Schmidt JJ, Seeliger B, Schmidt BMW, Welte T, Haller H, Hoeper MM, Budde U, Bode C, David S (2020) Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock. Crit Care 24:71. https:\/\/doi.org\/10.1186\/s13054-020-2799-5","journal-title":"Crit Care"},{"key":"6980_CR59","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, Pettila V, Wittebole X, Meziani F, Mercier E, Lobo SM, Barie PS, Crowther M, Esmon CT, Fareed J, Gando S, Gorelick KJ, Levi M, Mira JP, Opal SM, Parrillo J, Russell JA, Saito H, Tsuruta K, Sakai T, Fineberg D, Group ST (2019) Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA 321:1993\u20132002. https:\/\/doi.org\/10.1001\/jama.2019.5358","journal-title":"JAMA"},{"key":"6980_CR60","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/CCM.0000000000004426","volume":"48","author":"M Levi","year":"2020","unstructured":"Levi M, Vincent JL, Tanaka K, Radford AH, Kayanoki T, Fineberg DA, Hoppensteadt D, Fareed J (2020) Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy. Crit Care Med 48:1140\u20131147. https:\/\/doi.org\/10.1097\/CCM.0000000000004426","journal-title":"Crit Care Med"},{"key":"6980_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13613-021-00842-4","volume":"11","author":"B Fran\u00e7ois","year":"2021","unstructured":"Fran\u00e7ois B, Fiancette M, Helms J, Mercier E, Lascarrou JB, Kayanoki T, Tanaka K, Fineberg D, Vincent JL, Wittebole X (2021) Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET. Ann Intensive Care 11:53. https:\/\/doi.org\/10.1186\/s13613-021-00842-4","journal-title":"Ann Intensive Care"},{"key":"6980_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/SHK.0b013e3181aa95c4","volume":"33","author":"M Hayakawa","year":"2010","unstructured":"Hayakawa M, Katabami K, Wada T, Sugano M, Hoshino H, Sawamura A, Gando S (2010) Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients. Shock 33:14\u201318. https:\/\/doi.org\/10.1097\/SHK.0b013e3181aa95c4","journal-title":"Shock"},{"key":"6980_CR63","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/SLA.0000000000005603","volume":"276","author":"JP Hazelton","year":"2022","unstructured":"Hazelton JP, Ssentongo AE, Oh JS, Ssentongo P, Seamon MJ, Byrne JP, Armento IG, Jenkins DH, Braverman MA, Mentzer C, Leonard GC, Perea LL, Docherty CK, Dunn JA, Smoot B, Martin MJ, Badiee J, Luis AJ, Murray JL, Noorbakhsh MR, Babowice JE, Mains C, Madayag RM, Kaafarani HMA, Mokhtari AK, Moore SA, Madden K, Tanner A 2nd, Redmond D, Millia DJ, Brandolino A, Nguyen U, Chinchilli V, Armen SB, Porter JM (2022) Use of cold-stored whole blood is associated with improved mortality in hemostatic resuscitation of major bleeding: a multicenter study. Ann Surg 276:579\u2013588. https:\/\/doi.org\/10.1097\/SLA.0000000000005603","journal-title":"Ann Surg"},{"key":"6980_CR64","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/S2352-3026(22)00040-0","volume":"9","author":"N Crombie","year":"2022","unstructured":"Crombie N, Doughty HA, Bishop JRB, Desai A, Dixon EF, Hancox JM, Herbert MJ, Leech C, Lewis SJ, Nash MR, Naumann DN, Slinn G, Smith H, Smith IM, Wale RK, Wilson A, Ives N, Perkins GD, Pcg Re (2022) Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Haematol 9:e250\u2013e261. https:\/\/doi.org\/10.1016\/S2352-3026(22)00040-0","journal-title":"Lancet Haematol"},{"key":"6980_CR65","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(18)31553-8","volume":"392","author":"HB Moore","year":"2018","unstructured":"Moore HB, Moore EE, Chapman MP, McVaney K, Bryskiewicz G, Blechar R, Chin T, Burlew CC, Pieracci F, West FB, Fleming CD, Ghasabyan A, Chandler J, Silliman CC, Banerjee A, Sauaia A (2018) Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet 392:283\u2013291. https:\/\/doi.org\/10.1016\/S0140-6736(18)31553-8","journal-title":"Lancet"},{"key":"6980_CR66","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1056\/NEJMoa1802345","volume":"379","author":"JL Sperry","year":"2018","unstructured":"Sperry JL, Guyette FX, Brown JB, Yazer MH, Triulzi DJ, Early-Young BJ, Adams PW, Daley BJ, Miller RS, Harbrecht BG, Claridge JA, Phelan HA, Witham WR, Putnam AT, Duane TM, Alarcon LH, Callaway CW, Zuckerbraun BS, Neal MD, Rosengart MR, Forsythe RM, Billiar TR, Yealy DM, Peitzman AB, Zenati MS, Group PAS (2018) Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med 379:315\u2013326. https:\/\/doi.org\/10.1056\/NEJMoa1802345","journal-title":"N Engl J Med"},{"key":"6980_CR67","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2015.12","volume":"313","author":"JB Holcomb","year":"2015","unstructured":"Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, Muskat P, O\u2019Keeffe T, Rizoli S, Robinson BR, Scalea TM, Schreiber MA, Stein DM, Weinberg JA, Callum JL, Hess JR, Matijevic N, Miller CN, Pittet JF, Hoyt DB, Pearson GD, Leroux B, van Belle G, Group PS (2015) Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313:471\u2013482. https:\/\/doi.org\/10.1001\/jama.2015.12","journal-title":"JAMA"},{"key":"6980_CR68","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","volume":"389","author":"WT Collaborators","year":"2017","unstructured":"Collaborators WT (2017) Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 389:2105\u20132116. https:\/\/doi.org\/10.1016\/S0140-6736(17)30638-4","journal-title":"Lancet"},{"key":"6980_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","volume":"376","author":"C-T Collaborators","year":"2010","unstructured":"Collaborators C-T, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376:23\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(10)60835-5","journal-title":"Lancet"},{"key":"6980_CR70","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s13063-019-3663-2","volume":"20","author":"LJ Estcourt","year":"2019","unstructured":"Estcourt LJ, McQuilten Z, Powter G, Dyer C, Curnow E, Wood EM, Stanworth SJ, Collaboration TT (2019) The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial. Trials 20:592. https:\/\/doi.org\/10.1186\/s13063-019-3663-2","journal-title":"Trials"},{"key":"6980_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","volume":"5","author":"H Saito","year":"2007","unstructured":"Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, Hirayama A, Matsuda T, Asakura H, Nakashima M, Aoki N (2007) Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 5:31\u201341. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02267.x","journal-title":"J Thromb Haemost"},{"key":"6980_CR72","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1055\/s-0040-1715840","volume":"121","author":"K Taniguchi","year":"2021","unstructured":"Taniguchi K, Ohbe H, Yamakawa K, Matsui H, Fushimi K, Yasunaga H (2021) Recombinant thrombomodulin in disseminated intravascular coagulation associated with stage IV solid tumors: a nationwide observational study in Japan. Thromb Haemost 121:36\u201345. https:\/\/doi.org\/10.1055\/s-0040-1715840","journal-title":"Thromb Haemost"},{"key":"6980_CR73","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1186\/s12885-020-07375-2","volume":"20","author":"K Taniguchi","year":"2020","unstructured":"Taniguchi K, Ohbe H, Yamakawa K, Matsui H, Fushimi K, Yasunaga H (2020) Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan. BMC Cancer 20:867. https:\/\/doi.org\/10.1186\/s12885-020-07375-2","journal-title":"BMC Cancer"},{"key":"6980_CR74","doi-asserted-by":"publisher","DOI":"10.1055\/a-1530-3980","author":"EP Bianchini","year":"2021","unstructured":"Bianchini EP, Razanakolona M, Helms J, Zouiti F, Couteau-Chardon A, Marin-Esteban V, Chaisemartin L, De-Carvalho A, Bironien R, Chollet-Martin S, Denis CV, Diehl JL, Vasse M, Meziani F, Borgel D (2021) The proteolytic inactivation of protein z-dependent protease inhibitor by neutrophil elastase might promote the procoagulant activity of neutrophil extracellular traps in sepsis. Thromb Haemost. https:\/\/doi.org\/10.1055\/a-1530-3980","journal-title":"Thromb Haemost"},{"key":"6980_CR75","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1165\/rcmb.2020-0401OC","volume":"65","author":"R Clere-Jehl","year":"2021","unstructured":"Clere-Jehl R, Merdji H, Kassem M, Macquin C, De Cauwer A, Sibony A, Kurihara K, Minniti L, Abou Fay\u00e7al C, Bahram S, Meziani F, Helms J, Georgel P (2021) A translational investigation of IFN-\u03b1 and STAT1 signaling in endothelial cells during septic shock provides therapeutic perspectives. Am J Respir Cell Mol Biol 65:167\u2013175. https:\/\/doi.org\/10.1165\/rcmb.2020-0401OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"6980_CR76","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.thromres.2019.09.036","volume":"183","author":"L Stiel","year":"2019","unstructured":"Stiel L, Mayeur-Rousse C, Helms J, Meziani F, Mauvieux L (2019) First visualization of circulating neutrophil extracellular traps using cell fluorescence during human septic shock-induced disseminated intravascular coagulation. Thromb Res 183:153\u2013158. https:\/\/doi.org\/10.1016\/j.thromres.2019.09.036","journal-title":"Thromb Res"},{"key":"6980_CR77","doi-asserted-by":"publisher","first-page":"14270","DOI":"10.1096\/fj.201901363RRR","volume":"33","author":"D Barbosa da Cruz","year":"2019","unstructured":"Barbosa da Cruz D, Helms J, Aquino LR, Stiel L, Cougourdan L, Broussard C, Chafey P, Ri\u00e8s-Kautt M, Meziani F, Toti F, Gaussem P, Angl\u00e9s-Cano E (2019) DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma. FASEB J 33:14270\u201314280. https:\/\/doi.org\/10.1096\/fj.201901363RRR","journal-title":"FASEB J"},{"key":"6980_CR78","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13613-017-0340-z","volume":"7","author":"J Helms","year":"2017","unstructured":"Helms J, Clere-Jehl R, Bianchini E, Le Borgne P, Burban M, Zobairi F, Diehl JL, Grunebaum L, Toti F, Meziani F, Borgel D (2017) Thrombomodulin favors leukocyte microvesicle fibrinolytic activity, reduces NETosis and prevents septic shock-induced coagulopathy in rats. Ann Intensive Care 7:118. https:\/\/doi.org\/10.1186\/s13613-017-0340-z","journal-title":"Ann Intensive Care"},{"key":"6980_CR79","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/SHK.0000000000000719","volume":"47","author":"X Delabranche","year":"2017","unstructured":"Delabranche X, Stiel L, Severac F, Galoisy AC, Mauvieux L, Zobairi F, Lavigne T, Toti F, Angles-Cano E, Meziani F, Boisrame-Helms J (2017) Evidence of netosis in septic shock-induced disseminated intravascular coagulation. Shock 47:313\u2013317. https:\/\/doi.org\/10.1097\/SHK.0000000000000719","journal-title":"Shock"},{"key":"6980_CR80","doi-asserted-by":"publisher","first-page":"e1132","DOI":"10.1097\/CCM.0000000000001851","volume":"44","author":"L Stiel","year":"2016","unstructured":"Stiel L, Delabranche X, Galoisy AC, Severac F, Toti F, Mauvieux L, Meziani F, Boisrame-Helms J (2016) Neutrophil fluorescence: a new indicator of cell activation during septic shock-induced disseminated intravascular coagulation. Crit Care Med 44:e1132\u2013e1136. https:\/\/doi.org\/10.1097\/CCM.0000000000001851","journal-title":"Crit Care Med"},{"key":"6980_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06799-7","author":"APJ Vlaar","year":"2022","unstructured":"Vlaar APJ (2022) Blood transfusion: the search for the sweet spot. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-022-06799-7","journal-title":"Intensive Care Med"},{"key":"6980_CR82","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1007\/s00134-021-06531-x","volume":"47","author":"APJ Vlaar","year":"2021","unstructured":"Vlaar APJ, Dionne JC, de Bruin S, Wijnberge M, Raasveld SJ, van Baarle F, Antonelli M, Aubron C, Duranteau J, Juffermans NP, Meier J, Murphy GJ, Abbasciano R, Muller MCA, Lance M, Nielsen ND, Schochl H, Hunt BJ, Cecconi M, Oczkowski S (2021) Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med 47:1368\u20131392. https:\/\/doi.org\/10.1007\/s00134-021-06531-x","journal-title":"Intensive Care Med"},{"key":"6980_CR83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0140-6736(10)60939-7","volume":"376","author":"JH Levy","year":"2010","unstructured":"Levy JH (2010) Antifibrinolytic therapy: new data and new concepts. Lancet 376:3\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(10)60939-7","journal-title":"Lancet"},{"key":"6980_CR84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00134-020-06266-1","volume":"47","author":"K Baksaas-Aasen","year":"2021","unstructured":"Baksaas-Aasen K, Gall LS, Stensballe J, Juffermans NP, Curry N, Maegele M, Brooks A, Rourke C, Gillespie S, Murphy J, Maroni R, Vulliamy P, Henriksen HH, Pedersen KH, Kolstadbraaten KM, Wirtz MR, Kleinveld DJB, Schafer N, Chinna S, Davenport RA, Naess PA, Goslings JC, Eaglestone S, Stanworth S, Johansson PI, Gaarder C, Brohi K (2021) Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. Intensive Care Med 47:49\u201359. https:\/\/doi.org\/10.1007\/s00134-020-06266-1","journal-title":"Intensive Care Med"},{"key":"6980_CR85","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bjh.14885","volume":"179","author":"X Li","year":"2017","unstructured":"Li X, Ma X (2017) The role of heparin in sepsis: much more than just an anticoagulant. Br J Haematol 179:389\u2013398. https:\/\/doi.org\/10.1111\/bjh.14885","journal-title":"Br J Haematol"},{"key":"6980_CR86","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06850-7","author":"J Helms","year":"2022","unstructured":"Helms J, Middeldorp S, Spyropoulos AC (2022) Thromboprophylaxis in critical care. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-022-06850-7","journal-title":"Intensive Care Med"},{"key":"6980_CR87","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/EJA.0000000000000707","volume":"35","author":"J Duranteau","year":"2018","unstructured":"Duranteau J, Taccone FS, Verhamme P, Ageno W, Force EVGT (2018) European guidelines on perioperative venous thromboembolism prophylaxis: intensive care. Eur J Anaesthesiol 35:142\u2013146. https:\/\/doi.org\/10.1097\/EJA.0000000000000707","journal-title":"Eur J Anaesthesiol"},{"key":"6980_CR88","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","volume":"2","author":"HJ Schunemann","year":"2018","unstructured":"Schunemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, Rezende SM, Zakai NA, Bauer KA, Dentali F, Lansing J, Balduzzi S, Darzi A, Morgano GP, Neumann I, Nieuwlaat R, Yepes-Nunez JJ, Zhang Y, Wiercioch W (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv 2:3198\u20133225. https:\/\/doi.org\/10.1182\/bloodadvances.2018022954","journal-title":"Blood Adv"},{"key":"6980_CR89","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s13054-014-0563-4","volume":"18","author":"C Wang","year":"2014","unstructured":"Wang C, Chi C, Guo L, Wang X, Guo L, Sun J, Sun B, Liu S, Chang X, Li E (2014) Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis. Crit Care 18:563. https:\/\/doi.org\/10.1186\/s13054-014-0563-4","journal-title":"Crit Care"},{"key":"6980_CR90","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0049-3848(93)90109-2","volume":"72","author":"N Sakuragawa","year":"1993","unstructured":"Sakuragawa N, Hasegawa H, Maki M, Nakagawa M, Nakashima M (1993) Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)\u2013a multicenter co-operative double-blind trial in comparison with heparin. Thromb Res 72:475\u2013500. https:\/\/doi.org\/10.1016\/0049-3848(93)90109-2","journal-title":"Thromb Res"},{"issue":"2","key":"6980_CR91","doi-asserted-by":"publisher","first-page":"S264","DOI":"10.1007\/BF01740765","volume":"21","author":"F Fourrier","year":"1995","unstructured":"Fourrier F, Jourdain M, Tournois A, Caron C, Goudemand J, Chopin C (1995) Coagulation inhibitor substitution during sepsis. Intensive Care Med 21(2):S264-268","journal-title":"Intensive Care Med"},{"key":"6980_CR92","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/00003246-199903000-00042","volume":"27","author":"R Giebler","year":"1999","unstructured":"Giebler R, Schmidt U, Koch S, Peters J, Scherer R (1999) Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin. Crit Care Med 27:597\u2013604","journal-title":"Crit Care Med"},{"key":"6980_CR93","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00134-016-4225-7","volume":"42","author":"M Allingstrup","year":"2016","unstructured":"Allingstrup M, Wetterslev J, Ravn FB, Moller AM, Afshari A (2016) Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 42:505\u2013520. https:\/\/doi.org\/10.1007\/s00134-016-4225-7","journal-title":"Intensive Care Med"},{"key":"6980_CR94","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","volume":"286","author":"BL Warren","year":"2001","unstructured":"Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM, KyberSept Trial Study G (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286:1869\u20131878","journal-title":"JAMA"},{"key":"6980_CR95","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00134-003-1731-1","volume":"29","author":"JF Dhainaut","year":"2003","unstructured":"Dhainaut JF, Laterre PF, Janes JM, Bernard GR, Artigas A, Bakker J, Riess H, Basson BR, Charpentier J, Utterback BG, Vincent JL, Recombinant Human Activated Protein CWEISSG (2003) Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. Intensive Care Med 29:894\u2013903. https:\/\/doi.org\/10.1007\/s00134-003-1731-1","journal-title":"Intensive Care Med"},{"key":"6980_CR96","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/jth.12868","volume":"13","author":"M Levi","year":"2015","unstructured":"Levi M (2015) Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality. J Thromb Haemost 13:505\u2013507. https:\/\/doi.org\/10.1111\/jth.12868","journal-title":"J Thromb Haemost"},{"key":"6980_CR97","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00134-013-3054-1","volume":"39","author":"M Levi","year":"2013","unstructured":"Levi M, van der Poll T (2013) Endothelial injury in sepsis. Intensive Care Med 39:1839\u20131842. https:\/\/doi.org\/10.1007\/s00134-013-3054-1","journal-title":"Intensive Care Med"},{"key":"6980_CR98","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1046\/j.1538-7836.2003.00306.x","volume":"1","author":"H Weiler","year":"2003","unstructured":"Weiler H, Isermann BH (2003) Thrombomodulin. J Thromb Haemost 1:1515\u20131524. https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00306.x","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"6980_CR99","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1538-7836.2011.04319.x","volume":"9","author":"T Ito","year":"2011","unstructured":"Ito T, Maruyama I (2011) Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation. J Thromb Haemost 9(Suppl 1):168\u2013173. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04319.x","journal-title":"J Thromb Haemost"},{"key":"6980_CR100","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1423-0127-19-34","volume":"19","author":"YH Li","year":"2012","unstructured":"Li YH, Kuo CH, Shi GY, Wu HL (2012) The role of thrombomodulin lectin-like domain in inflammation. J Biomed Sci 19:34. https:\/\/doi.org\/10.1186\/1423-0127-19-34","journal-title":"J Biomed Sci"},{"key":"6980_CR101","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13473","author":"Y Umemura","year":"2016","unstructured":"Umemura Y, Yamakawa K (2016) Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials: reply. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.13473","journal-title":"J Thromb Haemost"},{"key":"6980_CR102","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jacc.2021.06.010","volume":"78","author":"C Hsu","year":"2021","unstructured":"Hsu C, Hutt E, Bloomfield DM, Gailani D, Weitz JI (2021) Factor XI inhibition to uncouple thrombosis from hemostasis: JACC review topic of the week. J Am Coll Cardiol 78:625\u2013631. https:\/\/doi.org\/10.1016\/j.jacc.2021.06.010","journal-title":"J Am Coll Cardiol"},{"key":"6980_CR103","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1182\/blood-2016-09-742262","volume":"129","author":"M Preis","year":"2017","unstructured":"Preis M, Hirsch J, Kotler A, Zoabi A, Stein N, Rennert G, Saliba W (2017) Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events. Blood 129:1210\u20131215. https:\/\/doi.org\/10.1182\/blood-2016-09-742262","journal-title":"Blood"},{"key":"6980_CR104","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1161\/ATVBAHA.116.306925","volume":"36","author":"D Gailani","year":"2016","unstructured":"Gailani D, Gruber A (2016) Factor XI as a therapeutic target. Arterioscler Thromb Vasc Biol 36:1316\u20131322. https:\/\/doi.org\/10.1161\/ATVBAHA.116.306925","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6980_CR105","doi-asserted-by":"publisher","first-page":"975767","DOI":"10.3389\/fcvm.2022.975767","volume":"9","author":"T Li","year":"2022","unstructured":"Li T, Liu J, Wu W (2022) Factor XI, a potential target for anticoagulation therapy for venous thromboembolism. Front Cardiovasc Med 9:975767. https:\/\/doi.org\/10.3389\/fcvm.2022.975767","journal-title":"Front Cardiovasc Med"},{"key":"6980_CR106","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1055\/a-1384-3715","volume":"41","author":"JC Fredenburgh","year":"2021","unstructured":"Fredenburgh JC, Weitz JI (2021) Factor XI as a target for new anticoagulants. Hamostaseologie 41:104\u2013110. https:\/\/doi.org\/10.1055\/a-1384-3715","journal-title":"Hamostaseologie"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-06980-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-023-06980-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-06980-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T05:03:13Z","timestamp":1678424593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-023-06980-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["6980"],"URL":"https:\/\/doi.org\/10.1007\/s00134-023-06980-6","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"8 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SG has no conflict of interest to declare. JH has received honoraria for lectures from Diagnostica Stago, Pfizer PFE France, Sanofi Aventis France, Inotrem, MSD, and Shionogi. TI participated in advisory boards of Japan Blood Products Organization, Asahi Kasei Pharmaceuticals, and Toray Medical. JMC reports personal fees for scientific advisory boards and consulting from Abbott, Anthos, Alnylam, Bristol Myers Squibb, Five Prime Therapeutics, Pfizer, Roche, and Sanofi, and research funding from CSL Behring. ML has received grants and has participated in advisory boards of NovoNordisk, Eli Lilly, Asahi Kasei Pharmaceuticals America, and Johnson & Johnson. FM has received funding from Diagnostica Stago and Octapharma. JHL serves on the Steering Committees for Instrumentation Laboratories, Merck, and Octapharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}